article 3 months old

Rudi’s View: Catalyst Metals, Dexus, Neuren, Stockland, ResMed & More

rudi-views
Always an independent thinker, Rudi has not shied away from making big out-of-consensus predictions that proved accurate later on. When Rio Tinto shares surged above $120 he wrote investors should sell. In mid-2008 he warned investors not to hold on to equities in oil producers. In August 2008 he predicted the largest sell-off in commodities stocks was about to follow. In 2009 he suggested Australian banks were an excellent buy. Between 2011 and 2015 Rudi consistently maintained investors were better off avoiding exposure to commodities and to commodities stocks. Post GFC, he dedicated his research to finding All-Weather Performers. See also "All-Weather Performers" on this website, as well as the Special Reports section.

Rudi's View | Sep 04 2025

List StockArray ( [0] => JHX [1] => CSL [2] => WTC [3] => AMC [4] => WOW [5] => GMG [6] => RMD [7] => PNI [8] => ANZ [9] => SGP [10] => CAR [11] => WTC [12] => XRO [13] => TLC [14] => BXB [15] => CBA [16] => NAB [17] => SGP [18] => MGR [19] => INA [20] => ASK [21] => CQR [22] => HMC [23] => GMG [24] => CHC [25] => ARF [26] => NSR [27] => HDN [28] => DXS [29] => LIC [30] => BWP [31] => COF [32] => CLW [33] => VCX [34] => CNI [35] => GPT [36] => CIP [37] => NST [38] => NEM [39] => CYL [40] => MEK [41] => MI6 [42] => GMD [43] => VAU [44] => EVN [45] => ALL [46] => ORI [47] => STO [48] => SUN [49] => FPH [50] => PME [51] => COH [52] => RHC [53] => MVF [54] => HLS [55] => NEU [56] => CU6 [57] => ACL [58] => SOM [59] => BOT [60] => IDX [61] => PYC [62] => EBR [63] => IMM [64] => IMR [65] => WDS )

This story features JAMES HARDIE INDUSTRIES PLC, and other companies.
For more info SHARE ANALYSIS: JHX

The company is included in ASX50, ASX100, ASX200, ASX300 and ALL-ORDS

In today's update:

-Another August Record: Volatility!
-Greenshoots For Resi
-A-REITs Are Winners
-Gold Bull Awakens
-No Change At Morgan Stanley
-Healthcare Needs A Cure

By Rudi Filapek-Vandyck, Editor

When I finished writing Weekly Insights on Tuesday afternoon, it was my intention to dig deeper into individual companies and performances during the August results season, but time has not worked in my favour on Thursday.

So that idea has now shifted to the next Weekly Insights coming Monday. Meanwhile, below are some of the cherries from analysts’ conclusions and responses post August results.

Another August Record: Voilatility!

If your impression is that volatility for Australian equity has seldom been as high during results season as in the past month, you’re most likely on the mark.

Some statistics gathered by analysts at Wilsons:

-Average post-result intraday trading range 7.7% (a record)
-Circa 50% of ASX200 constituents experienced share price moves of 5% or more
-Some 30% of on-the-day share price moves exceeded 10%

Among the heaviest hit were large caps James Hardie ((JHX)), down -25%, CSL ((CSL)), down -21%, WiseTech Global ((WTC)), down -15%, Amcor ((AMC)), down -11%, and Woolworths Group ((WOW)), down -9%.

August results triggered a number of changes for Wilsons’ Focus Portfolio.

On reduced confidence, exposure to CSL has been downgraded (by half) while no confidence was left after James Hardie’s newest debacle, so all shares in that company have been divested.

Winners already in the Portfolio that saw their weighting increased; Goodman Group ((GMG)), ResMed ((RMD)) and Pinnacle Investment Management ((PNI)).

Post August, the Portfolio’s largest overweight positions are ANZ Bank ((ANZ)), ResMed, Pinnacle Investment Management and Goodman Group.

Other high conviction holdings currently include Stockland ((SGP)), CAR Group ((CAR)), WiseTech Global ((WTC)), Xero ((XRO)), The Lottery Corp ((TLC)), and Brambles ((BXB)).

From a sector perspective, the Focus Portfolio’s largest overweights are in Consumer Services, Technology and Real Estate.

Banks remain underweighted through no exposure to CommBank ((CBA)) or National Australia Bank ((NAB)), with the analysts referring to valuation concerns and uncompelling growth.

Greenshoots For Resi

One of the greenshoots that emerged from the August reporting season is a renewed uptrend in residential property development and the general consensus seems to be that Stockland ((SGP)) is the best option available on the ASX to seek leverage to the theme.

As mentioned above, Wilsons’ Model Portfolio added the stock following the release of FY25 financials in August. Sector analysts at Morgan Stanley too have articulated their preference for Stockland over Mirvac Group ((MGR)), though both should be natural beneficiaries.

Depending on how strong exactly the sector upswing will prove to be, and further RBA rate cuts might prove influential in this regard, but Morgan Stanley suggests both companies should achieve guidance for the year ahead, with risk to the upside.

Stockland is preferred because it has a relatively higher exposure to the residential segment, construction risk is deemed lower and the shares are trading on a cheaper valuation.

A-REITs Are Winners

Another sector that marked August as a true ‘come back’ experience are ASX-listed REITs. Jarden’s sector analysts report “there is much to be excited about”.

Not unimportant: Jarden is counting on two further RBA rate cuts over the coming 6-9 months.

Among the positives cited are transaction volumes picking up, cap rates starting to move down while rental/price growth, helped by limited supply across most asset classes, is driving up asset values. Also: balance sheets across the sector are in good shape and most REITs have a range of capital management options to fund the next leg of the growth cycle.

Jarden’s post-August sector update includes no fewer than 16 fresh price targets and four rating changes. The over-riding conclusion is there should be ample of opportunity to achieve double-digit gains from the sector in the year ahead.

Firstly, the rating changes. Ingenia Communities ((INA)) has been upgraded to Buy from Overweight. Both Abacus Storage King ((ASK)) and Charter Hall Retail REIT ((CQR)) have been upgraded to Overweight from Neutral. Overweight sits in between Buy and Neutral.

The one downgrade went to HMC Capital ((HMC)), former highflyer whose market update flopped in August, with Jarden’s rating falling to Neutral from Overweight.

Now over to the sector team’s preferences. At this point of the cycle, Jarden continues to like active fund managers in the sector, which in this case reflects well on both Goodman Group ((GMG)) and Charter Hall ((CHC)).

For exposure to residential property through REITs, Jarden’s favourite is Ingenia Communities. Again (see also above), Stockland is preferred over Mirvac.

Jarden also likes Self-storage and Arena REIT ((ARF)).

Are all rated Buy:

-Goodman Group
-Ingenia Communities
-National Storage ((NSR))
-HomeCo Daily Needs REIT ((HDN))

Seven more REITs are rated Overweight. Seven others are rated Neutral.

This leaves the following on Underweight:

-Dexus ((DXS))
-Lifestyle Communities ((LIC))
-BWP Trust ((BWP))
-Centuria Office ((COF))
-Charter Hall long WALE ((CLW))

Jarden has currently no Sell ratings in this sector.

Sector analysts at UBS are a little less bullish, but still positively biased overall. UBS finds the sector is now much more “fairly” valued, following a positive August experience, but further upside can definitely be achieved on the back of RBA rate cuts or stronger earnings growth “if accretive acquisitions can be equity funded”.

UBS has Sell ratings for Vicinity Centres ((VCX)) and Charter Hall. While Goodman Group’s FY25 update didn’t quite meet high expectations, the shares are still expected to find solid support.

The one key negative market update last month is identified as the one delivered by Centuria Office. Key standout results, as far as UBS is concerned, were released by Centuria Capital Group ((CNI)), Stockland, Lifestyle Communities, and GPT Group ((GPT)).

This broker’s Key Buy ratings are reserved for Dexus, Lifestyle Communities, Centuria Industrial REIT ((CIP)), BWP Trust, and National Storage.

Gold Bull Awakens

The local gold mining sector crowned itself as one of the stand-out performers in August. A renewed uptrend for the price of bullion provided the necessary trigger as the world’s anxiety grows (yet again) about how governments in Europe and inside the Whitehouse plan to finance their budget deficits.

Analysts at Morgans see plenty of evidence a fresh bull market for the sector is unfolding. Among the signals: significant capital flowing into small and micro-cap equity exposures.

Morgans has lifted its long-term bullion price forecast to US$2500/oz from US$2200.

And now for the tricky part; amongst the many (and strong) share price rallies, which ASX-listed gold miner/explorer/developer is still a comfortable Buy?

Morgans prefers Northern Star ((NST)) over Newmont Corp ((NEM)), Catalyst Metals ((CYL)) among MidCappers, and rates alternative favourites Meeka Metals ((MEK)) and Minerals 260 ((MI6)) both as Speculative Buys.

A few days ahead of Morgans’ update, gold sector analysts at Macquarie had equally switched their preference among large caps to Northern Star from Newmont.

Among MidCaps, Macquarie prefers Genesis Minerals ((GMD)) and Vault Minerals ((VAU)).

Only one Underperform rating is currently active at Macquarie and it’s reserved for Evolution Mining ((EVN)).

No Change At Morgan Stanley

In contrast with Wilsons’ Focus List (above), Morgan Stanley’s Australia Macro+ Focus List has seen no changes since April this year.

Hence, the ten stocks included remain (note the continuous inclusion of James Hardie):

-Aristocrat Leisure ((ALL))
-ANZ Bank
-Car Group
-Goodman Group
-GPT Group
-James Hardie
-Orica ((ORI))
-Santos ((STO))
-Suncorp Group ((SUN))
-Xero

Healthcare Needs A Cure

The title of most disappointing sector in August goes to Healthcare and analysts at Wilsons, for one, report they cannot remember a time when the disparity between companies in the sector they like or dislike has been as stark as post August 2025.

Wilsons number one sector favourite –“far and away”– is ResMed, with Fisher & Paykel Healthcare ((FPH)) a distant second.

During August, Wilsons upgraded Pro Medicus ((PME)) to Overweight. Cochlear ((COH)) is believed to be cum downgrade.

And while the analysts are happy to keep CSL on Marketweight, they’d hoped to become more positive on each of Ramsay Health Care ((RHC)), Monash IVF ((MVF)) and Healius ((HLS)), but were disappointed, yet again.

Other favourites are Neuren Pharmaceuticals ((NEU)), Clarity Pharmaceuticals ((CU6)), Clinical Labs ((ACL)), and Somnomed ((SOM)).

Healthcare sector analysts at Canaccord Genuity have identified their candidates for a re-rating over the year ahead. Ahead of the plans to merge with Wilsons, Canaccord’s focus is still very much on the smaller end of the ASX.

Key stocks to potentially re-rate over the next 6 months:

-Botanix Pharmaceuticals ((BOT))
-Clarity Pharmaceuticals
-Integral Diagnostics ((IDX))
-PYC Therapeutics ((PYC))

Key stocks to potentially re-rate over the next 12 months:
-EBR Systems ((EBR))
-Immutep ((IMM))
-Imricor Medical Systems ((IMR))
-Neuren Pharmaceuticals

P.S. Whenever RBC Capital releases a list of international key picks for exposure to energy it standard features Woodside Energy ((WDS)). That has not changed.

(Do note that, in line with all my analyses, appearances and presentations, all of the above names and calculations are provided for educational purposes only. Investors should always consult with their licensed investment advisor first, before making any decisions.)  

P.S. I – All paying members at FNArena are being reminded they can set an email alert for my Rudi’s View stories. Go to My Alerts (top bar of the website) and tick the box in front of ‘Rudi’s View’. You will receive an email alert every time a new Rudi’s View story has been published on the website. 

P.S. II – If you are reading this story through a third party distribution channel and you cannot see charts included, we apologise, but technical limitations are to blame.

FNArena Subscription

A subscription to FNArena (6 or 12 months) comes with an archive of Special Reports (20 since 2006); examples below.

Not About The Banks 250Dividend Investing, The Smart Way 250Cover Investing in GenAi - medium sized

Find out why FNArena subscribers like the service so much: “Your Feedback (Thank You)” – Warning this story contains unashamedly positive feedback on the service provided.

FNArena is proud about its track record and past achievements: Ten Years On

To share this story on social media platforms, click on the symbols below.

Click to view our Glossary of Financial Terms

CHARTS

ACL ALL AMC ANZ ARF ASK BOT BWP BXB CAR CBA CHC CIP CLW CNI COF COH CQR CSL CU6 CYL DXS EBR EVN FPH GMD GMG GPT HDN HLS HMC IDX IMM IMR INA JHX LIC MEK MGR MI6 MVF NAB NEM NEU NSR NST ORI PME PNI PYC RHC RMD SGP SOM STO SUN TLC VAU VCX WDS WOW WTC XRO

For more info SHARE ANALYSIS: ACL - AUSTRALIAN CLINICAL LABS LIMITED

For more info SHARE ANALYSIS: ALL - ARISTOCRAT LEISURE LIMITED

For more info SHARE ANALYSIS: AMC - AMCOR PLC

For more info SHARE ANALYSIS: ANZ - ANZ GROUP HOLDINGS LIMITED

For more info SHARE ANALYSIS: ARF - ARENA REIT

For more info SHARE ANALYSIS: ASK - ABACUS STORAGE KING

For more info SHARE ANALYSIS: BOT - BOTANIX PHARMACEUTICALS LIMITED

For more info SHARE ANALYSIS: BWP - BWP TRUST

For more info SHARE ANALYSIS: BXB - BRAMBLES LIMITED

For more info SHARE ANALYSIS: CAR - CAR GROUP LIMITED

For more info SHARE ANALYSIS: CBA - COMMONWEALTH BANK OF AUSTRALIA

For more info SHARE ANALYSIS: CHC - CHARTER HALL GROUP

For more info SHARE ANALYSIS: CIP - CENTURIA INDUSTRIAL REIT

For more info SHARE ANALYSIS: CLW - CHARTER HALL LONG WALE REIT

For more info SHARE ANALYSIS: CNI - CENTURIA CAPITAL GROUP

For more info SHARE ANALYSIS: COF - CENTURIA OFFICE REIT

For more info SHARE ANALYSIS: COH - COCHLEAR LIMITED

For more info SHARE ANALYSIS: CQR - CHARTER HALL RETAIL REIT

For more info SHARE ANALYSIS: CSL - CSL LIMITED

For more info SHARE ANALYSIS: CU6 - CLARITY PHARMACEUTICALS LIMITED

For more info SHARE ANALYSIS: CYL - CATALYST METALS LIMITED

For more info SHARE ANALYSIS: DXS - DEXUS

For more info SHARE ANALYSIS: EBR - EBR SYSTEMS INC

For more info SHARE ANALYSIS: EVN - EVOLUTION MINING LIMITED

For more info SHARE ANALYSIS: GMD - GENESIS MINERALS LIMITED

For more info SHARE ANALYSIS: GMG - GOODMAN GROUP

For more info SHARE ANALYSIS: GPT - GPT GROUP

For more info SHARE ANALYSIS: HDN - HOMECO DAILY NEEDS REIT

For more info SHARE ANALYSIS: HLS - HEALIUS LIMITED

For more info SHARE ANALYSIS: HMC - HMC CAPITAL LIMITED

For more info SHARE ANALYSIS: IDX - INTEGRAL DIAGNOSTICS LIMITED

For more info SHARE ANALYSIS: IMM - IMMUTEP LIMITED

For more info SHARE ANALYSIS: IMR - IMRICOR MEDICAL SYSTEMS INC

For more info SHARE ANALYSIS: INA - INGENIA COMMUNITIES GROUP

For more info SHARE ANALYSIS: JHX - JAMES HARDIE INDUSTRIES PLC

For more info SHARE ANALYSIS: LIC - LIFESTYLE COMMUNITIES LIMITED

For more info SHARE ANALYSIS: MEK - MEEKA METALS LIMITED

For more info SHARE ANALYSIS: MGR - MIRVAC GROUP

For more info SHARE ANALYSIS: MI6 - MINERALS 260 LIMITED

For more info SHARE ANALYSIS: MVF - MONASH IVF GROUP LIMITED

For more info SHARE ANALYSIS: NAB - NATIONAL AUSTRALIA BANK LIMITED

For more info SHARE ANALYSIS: NEM - NEWMONT CORPORATION REGISTERED

For more info SHARE ANALYSIS: NEU - NEUREN PHARMACEUTICALS LIMITED

For more info SHARE ANALYSIS: NSR - NATIONAL STORAGE REIT

For more info SHARE ANALYSIS: NST - NORTHERN STAR RESOURCES LIMITED

For more info SHARE ANALYSIS: ORI - ORICA LIMITED

For more info SHARE ANALYSIS: PME - PRO MEDICUS LIMITED

For more info SHARE ANALYSIS: PYC - PYC THERAPEUTICS LIMITED

For more info SHARE ANALYSIS: RHC - RAMSAY HEALTH CARE LIMITED

For more info SHARE ANALYSIS: RMD - RESMED INC

For more info SHARE ANALYSIS: SGP - STOCKLAND

For more info SHARE ANALYSIS: SOM - SOMNOMED LIMITED

For more info SHARE ANALYSIS: STO - SANTOS LIMITED

For more info SHARE ANALYSIS: SUN - SUNCORP GROUP LIMITED

For more info SHARE ANALYSIS: TLC - LOTTERY CORPORATION LIMITED

For more info SHARE ANALYSIS: VAU - VAULT MINERALS LIMITED

For more info SHARE ANALYSIS: VCX - VICINITY CENTRES

For more info SHARE ANALYSIS: WDS - WOODSIDE ENERGY GROUP LIMITED

For more info SHARE ANALYSIS: WOW - WOOLWORTHS GROUP LIMITED

For more info SHARE ANALYSIS: WTC - WISETECH GLOBAL LIMITED

For more info SHARE ANALYSIS: XRO - XERO LIMITED

Australian investors stay informed with FNArena – your trusted source for Australian financial news. We deliver expert analysis, daily updates on the ASX and commodity markets, and deep insights into companies on the ASX200 and ASX300, and beyond. Whether you're seeking a reliable financial newsletter or comprehensive finance news and detailed insights, FNArena offers unmatched coverage of the stock market news that matters. As a leading financial online newspaper, we help you stay ahead in the fast-moving world of Australian finance news.